Membrane dipeptidase (MDP) is a zinc metalloenzyme located in the lungs and on the brush border membranes of the kidney and intestine. The gene for MDP (also termed DPEP1) is both frequently lost in Wilm's tumours and is located on human chromosome 16q24.3, a region of the genome known to contain a tumour suppressor gene(s). We now report on the regulation of MDP gene expression in normal and transformed cells. MDP enzyme activity and mRNA was detected in primary baby rat kidney (BRK) cells maintained in culture for up to 4 weeks. In contrast all stable transformed cell lines that were tested, derived either by transformation with the DNA tumour viruses SV40 or adenovirus, or in human tumour cell lines, contained very low levels of or no detectable MDP mRNA or enzyme activity. In BRK cells transformed by the temperaturesensitive tsA58 mutant of SV40 T antigen, MDP activity was not detectable, in cell lines grown at the permissive temperature (338C) but after 5 ± 14 days of incubation at the non-permissive temperature (39.58C), MDP protein and enzyme activity could be readily detected. Taken together, these results indicate that MDP expression is characteristic of dierentiated kidney epithelial cells and is down-regulated in proliferating, transformed cells.
Keywords: SV40; adenoviruses; cell transformation; tumour cells; peptidases Membrane dipeptidase (MDP; previously termed dehydropeptidase-I, microsomal or renal dipeptidase; EC 3.4.13.19) is a glycosyl-phosphatidylinositol (GPI) anchored cell-surface metalloenzyme present in a number of tissues including the kidneys, lungs, intestine and pancreas (reviewed in Keynan et al., 1996) and is characteristically inhibited by cilastatin. MDP cDNAs have been cloned from the human, pig, rabbit, rat, mouse and sheep (Adachi et al., 1990 Rached et al., 1990; Igarashi and Karniski, 1991; Satoh et al., 1993a,b; An et al., 1994) and the predicted proteins showed high homology between species but no homology was found with any known mammalian protein. In the mouse, at least four MDP mRNAs have been detected which are products of one MDP gene, generated by dierential usage of two promoters and poly(A) + sites (Habib et al., 1996) . The MDP gene (also termed DPEP1) was found to be located on human chromosome 16q24.3 (Nakagawa et al., 1992; Austruy et al., 1993a) . Over the last few years evidence has accumulated to show that chromosome 16q24.3 contains a putative tumour suppressor gene. Loss of alleles in this region of the long arm of chromosome 16 has been described in Wilm's tumour (Maw et al., 1992; Austruy et al., 1993b) , hepatocellular, prostatic and breast carcinomas (Seizinger et al., 1991) . MDP gene deletions were detected in 24% and MDP mRNA was absent in approximately 72% of Wilm's tumours analysed (Austruy et al., 1993b ). An inherited lysosomal storage disorder, mucopolysaccharidosis, is also associated with deletions in 16q24.3 (Fukuda et al., 1996) . This disorder results from deletions in the Nacetylgalactosamine-6-sulphate transferase gene which does not give rise to tumour formation, but interestingly the MDP gene remains intact. Together, these studies lend increased relevance to the study of known genes in the 16q24.3 region, in particular the MDP gene, which might ful®l the functions of tumour suppressor genes.
To begin studies on the possible relationship between MDP expression, cell proliferation and oncogenesis in cells of renal origin, we analysed MDP expression in primary baby rat kidney (BRK) cells, in BRK cells transformed by DNA tumour viruses and in established human cell lines derived from kidney and intestinal sources. MDP activity was assayed in various cell lines derived from kidney, intestine or related tissue. Normal baby rat kidney cells (BRK) were used as a positive control where MDP is expressed and highly active (with a speci®c activity of 8.72 nmol/mg total cell protein/min). Several lines of BRK cells transformed by the entire adenovirus (Ad) transforming region, comprising the E1A and E1B oncogenes (Boulanger and Blair, 1991) of either Ad5 or Ad12 had no detectable MDP enzyme activity. Ad5-transformed human embryonic kidney cells, 293 cells (Graham et al., 1977) , also did not contain detectable MDP activity, showing that loss of MDP in transformed kidney cells was not species-related. We then analysed MDP enzyme levels in BRK cell lines that had been generated by transformation with a plasmid, pBSVearly, which contains the transforming region of an unrelated DNA tumour virus, SV40 (Schaner, 1980) . As expected, MDP activity was completely absent in four independent SV40-transformed BRK cell lines, termed SV2, SV4, SV5 and SV6 (Blair Zajdel and Blair, 1988) . The level of other cellsurface enzymes, such as angiotensin-converting enzyme and endopeptidase 24.11 (neprilysin), were not altered by Ad-or SV40-transformation (results not shown), in clear contrast to the results obtained with MDP. Several established, well-characterized human tumour cell lines of intestinal origin (WiDr, HT29 and HCT8) were also negative for cell-surface MDP.
The results obtained above could be explained by a loss of MDP expression as BRK or other cells are cultured in vitro. We therefore maintained primary BRK cells for up to 4 weeks in culture, passaging the cells and assaying MDP activity on a weekly basis and were able to show that over this period there was no loss of MDP speci®c activity, with a mean value of 12.49+4.79 nmol/min/mg total cell protein (n=4). Since all the cell lines described above had been established many years ago and were analysed at relatively high passage number we decided to transform fresh BRK cells with the plasmid containing the SV40 transforming region, pBSVearly (Schaner, 1980) . After several (2 ± 3) weeks, eight independent clones were isolated from foci of transformed cells and plated in separate wells. These cell lines displayed characteristics expected of SV40-transformed cells. Each cell line was positive for the large T antigen:p53 complex by indirect immuno¯uorescent antibody staining using the monoclonal antibodies PAb419, for SV40 large T antigen and PAb421, for p53 (Harlow et al., 1981) while, as expected, normal BRK cells were negative (results not shown). MDP activity was measured in whole cell extracts derived from the eight clones at low passage, after not more than 4 weeks following transformation. In most of the freshlyestablished clones MDP activity was reduced by more than 90%, while in two clones enzyme activity was completely abolished. We therefore concluded that loss of MDP activity in SV40-transformed BRK cells could not simply be explained by loss of the enzyme in cultured cells grown to high passage.
In order to determine whether the lack of expression of MDP enzyme activity was due to a loss of MDP mRNA transcripts, we prepared total mRNA from several SV40-transformed BRK cell lines as well as from normal BRK cells and analysed for the presence of MDP mRNA by RT ± PCR ( Figure 1 ). As controls, we used primers which amplify a 780 bp fragment of rat b-actin cDNA (Figure 1a ) while MDP mRNA was assayed using rat MDP-speci®c primers which ampli®ed two fragments of 1000 bp and 480 bp, corresponding to products derived by ampli®cation of genomic DNA and cDNA respectively (Figure 1b) . The 1000 bp fragment could also be generated by reverse transcription and ampli®cation of unprocessed MDP premRNA. As a positive control, mouse kidney cDNA was used (Figure 1b Graham (1980) . Baby rat kidney (BRK) cells (around 70% con¯uent in 60 mm dishes) were transfected using 10 mg of pBSVearly DNA and LipofectAmine (Gibco BRL) following the manufacturers instructions. Foci of transformed cells were visible 10 ± 14 days after transfection and were picked and expanded into cell lines for further analysis. RT ± PCR analysis of mRNA was performed using rat b-actin primers (Gibco BRL), 5'-GAT CTT GAT CTT CAT GGT GCT AGG-3' and 5'-TTG TAA CCA ACT GGG ACG -ATA TGG -3'. Total RNA was isolated with a single step method using TRIzol reagent (Gibco BRL). Oligo(dT)-primed synthesis of cDNA was done in 30 ml containing 5 ml of total RNA, 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 0.5 mM dNTPs, 1 mg oligo(dT) 12 ± 18 , 20 units of RNAsin (Pharmacia) and 300 units of Moloney murine leukemia virus (MMLV) reverse transcriptase (Gibco BRL). The synthesis of cDNA was performed at 428C for 90 min. PCR reactions (50 ml) were performed using 200 ng of the ®rst strand cDNA, 10 mM Tris-HCl (pH 8. Rached et al., 1990) was used as a probe in the hybridization using the method described in Sambrook et al. (1989) . In a ± c, lane 1, no DNA; lanes 2 and 3, normal BRK cDNA; lane 4, SV4 cDNA; lane 5, SV5 cDNA; lane 6, SV6 cDNA; lane 7, mouse kidney cDNA; lane 8, DNA molecular size ladder of 100 bp. The arrow refers to an ampli®ed cDNA of 480 bp; the slower-migrating band (which also hybridizes to the pig cDNA probe in c) is a 1000 bp MDP PCR product derived from genomic DNA of the 480 bp MDP cDNA product was detected in any of the SV40-transformed cell lines (Figure 1, lane  4) . To ensure that the 480 bp fragments encoded parts of MDP and to increase the sensitivity of detection of MDP cDNA further, the PCR products were analysed on a 1% agarose gel, transferred to a nitrocellulose membrane and hybridized with a 32 P-labelled 630 bp SunI/EagI fragment of pig MDP cDNA (Figure 1c) . Only lanes 2, 3 and 7 (corresponding to normal BRK and mouse kidney cDNA respectively), showed hybridization between the 480 bp cDNA product and the pig MDP probe. Only a trace amount of hybridization was detected to the 480 bp RT ± PCR products derived from SV40-transformed BRK cells (Figure 1, lanes 4, 5 and 6 ). These results suggested that the lowered levels of MDP activity in SV40-transformed cells were due to the relatively low level of MDP mRNA transcripts.
We further investigated the role of SV40 transformation in suppressing MDP expression using transformed BRK cells expressing a thermolabile mutant large T antigen. The purpose of this approach was to distinguish between active repression of MDP gene expression and irreversible eects on the MDP gene (e.g. by insertional inactivation of the MDP gene due to SV40 integration). BRK cells were transformed with a plasmid containing a mutant SV40 genome encoding a temperature-sensitive SV40 T antigen, tsA58. After several weeks of growth at 338C, foci were isolated and tested for large T antigen expression by indirect immuno¯uorescence using the monoclonal antibody PAb419. Cells derived from all foci were positive for large T antigen expression when cultures were maintained at 338C but¯uorescence intensity was greatly reduced after shifting the temperature up to 39.58C for 3 days (results not shown). Transformed cell lysates were also tested for their large T antigen content by Western blotting with the monoclonal antibody PAb419. Only transformed cells that had been incubated at the permissive temperature of 338C contained immunoreactive large T antigen (Figure 2c) . Similar results were obtained with other tsSV clonal cell lines (results not shown). Half of the cells from each clone were then incubated at 338C, the permissive BRK cells were prepared and transfected with the tsA58 plasmid as described in Figure 1 . Transformed foci were picked after 4 ± 5 weeks at 338C and tested for SV40 large T antigen expression. The T antigen-positive transformed cell lines (tsSV1, 5 and 8) were placed either at 338C or at the non-permissive temperature of 39.58C. MDP activity was assayed in cell membranes puri®ed from transformed cells after 5 days as described previously (Keynan et al., 1994) . Protein concentrations were determined using the bicinchoninic acid method (Pierce, UK) with bovine serum albumin as standard. The results in the . After 5 days of incubation, membranes were prepared as previously described (Keynan et al., 1994) . Aliquots of cell membrane extracts (containing 10 mg of protein) were analysed by SDS ± PAGE (Laemmli, 1970) under non-reducing conditions, electroblotted and reacted with 1 : 500 dilution of a polyclonal anti-mouse MDP antibody (Littlewood et al., 1989) in the presence of 5% goat serum (to block non-speci®c antibody binding). The detection of bound antibody was performed using the ECL kit (Amersham, UK). Lane 1, 100 ng pure rat MDP; lane 2, tsSV5 at 338C; lane 3, tsSV5 at 39.58C. (b) PI-PLC release of MDP from normal BRK cells and SV40 tsA-transformed BRK cells. Cells were maintained at 338C or 39.58C for 14 days. Aliquots of cell lysates (containing 50 mg protein) were incubated in the presence of PI-PLC for 1 h at 378C. Subsequently 100 ml of cilastatin-Sepharose beads were added and the mixture was allowed to rotate (end over end) for 16 h at 48C. The beads were washed ®ve times with 50 mM Tris-HCl pH 7.5 containing 500 mM NaCl, SDS sample buer was added and the samples were analysed by SDS ± PAGE under non-reducing conditions and immunoblotting as described above. Lane 1, normal BRK cells; lane 2, tsSV5 at 338C; lane 3, tsSV5 at 39.58C. (c) The steady-state level of SV40 large T antigen in SV40 tsAtransformed BRK cells. Normal BRK or tsSV5 cells were maintained at 338C or 39.58C. After 14 days, whole cell lysates were prepared using 10 mM Tris-HCl pH 7.5 buer containing 1% Triton X-100, 1% NP-40 and 100 mM NaCl. Aliquots of cell lysates (100 mg of protein) were analysed by reducing SDS ± PAGE followed by immunoblotting using a mouse monoclonal antibody, PAb419, against SV40 large T antigen. Lane 1, BRK at 338C; lane 2, BRK at 39.58C; lane 3, tsSV5 at 338C; lane 4, tsSV5 at 39.58C. SV40 large T antigen, migrating with an apparent molecular mass of approximately 90 kDa, is indicated by an arrow temperature for the tsA58 T antigen, while the other half were incubated at 39.58C. After 5 days in culture, cells maintained at both temperatures were harvested, cell membranes were prepared and assayed for MDP activity (Table 1) . MDP activity was either very low (tsSV8) or undetectable (tsSV1 and 5) when cells were maintained at 338C. However, when cells were incubated at 39.58C, MDP activity was signi®cantly elevated after 5 days at 39.58C (Table 1) and MDP expression could still be detected 14 days after shift-up (Figure 2 and results not shown) .
A rabbit polyclonal antibody raised against puri®ed mouse kidney MDP was used to detect steady-state levels of rat MDP protein by SDS ± PAGE and Western blot analysis. Membranes from BRK cells and tsA58-transformed BRK cell lines after 5 days in culture at either 338C or 39.58C were analysed on Western blots using the anti-mouse MDP antibody (Figure 2) . In membranes isolated from tsSV5 cells maintained at 39.58C, a band was detected (Figure 2a Table 1 behaved identically to tsSV5 cells in terms of induction of MDP at 39.58C (results not shown). In order to determine whether the enzyme that was synthesized at 39.58C behaved identically to the normal enzyme, we examined the susceptibility of MDP to release from plasma membranes and binding of MDP to a well-characterized inhibitor, cilastatin (Kahan et al., 1983) . Whole cell lysates were prepared from tsSV5 cells maintained at 338C and 39.58C for 14 days. The lysates were treated with bacterial phosphatidylinositol-speci®c phospholipase C (PI-PLC) and bound to cilastatin-Sepharose. Bound MDP was analysed by immunoblotting (Figure 2b ). PI-PLC was able to release MDP from normal BRK cells in a form that could bind to cilastatin-Sepharose (Figure 2b , lane 1). Similarly, MDP was released from tsSV5 cells grown at 39.58C (Figure 2b, lane 3) but not from cells grown at 338C (Figure 2b, lane 2) .
On shift-up to the higher temperature, cell proliferation ceases in tsA-transformed cells and cell differentiation takes place over a period of several days (Verity et al., 1993) . Other reports have described the induction of apoptosis in tsA-transformed rat fibroblast cells on shift-up (GueÂ nal and Mignotte, 1995) . In this study, a dierent cell type was used for transformation, baby rat kidney cells, which consists mainly of cells derived from the proximal tubule of the kidney (Nanus and Albino, 1993) . Changes in the expression of cellular genes involved in apoptosis, including those genes whose expression is p53-dependent (such as Waf1/Cip1 and mdm-2), are induced within hours of shift-up to the restrictive temperature (GueÂ nal and Mignotte, 1995) , whereas in this study MDP expression was detected only after several days at the restrictive temperature and was maintained for up to 14 days at 39.58C. This would point towards the expression of MDP as being a characteristic of the dierentiated phenotype of proximal kidney cells, rather than being a manifestation of apoptosis.
The precise mechanism of down-regulation of MDP expression in SV40-transformed BRK cells remains to be elucidated. The low level of MDP mRNA transcripts found in SV40-transformed cells could arise either by transcriptional repression mediated by T antigen or by down-regulation of a post-transcriptional step (e.g. RNA splicing, mRNA export, decreased mRNA stability etc.). Further studies on MDP mRNA transcription are required to elucidate the mechanism of down-regulation in transformed cells. Virally-transformed BRK cells appear to be an excellent model for the study of MDP expression in kidney cells since they recapitulate the loss of expression of MDP mRNA frequently noted in Wilm's tumour cell lines (Austruy et al., 1993b) .
Is MDP a candidate tumour suppressor gene? At present, evidence in favour of this hypothesis comprises the genomic location of MDP, in a region of chromosome 16 known to contain at least one tumour suppressor gene and the loss of expression of MDP in Wilm's tumour (Austruy et al., 1993b) and actively proliferating transformed cells, shown in this study. If MDP is a tumour suppressor, the mechanism of growth suppression may be expected to be dierent to that exerted by other tumour suppressor gene products that function in the nucleus or the cytoplasm since MDP is a cell-surface enzyme. Since one substrate of MDP is glutathione (Kozak and Tate, 1982) , one possibility might be that MDP functions in the control of cell proliferation by regulation of the metabolism of glutathione. Control of the intracellular redox state is maintained by the level of glutathione and its oxidized and reduced forms and is critical for many processes. These include the regulation of certain transcription factors such as AP1 (Abate et al., 1990) and NF-kB (Matthews et al., 1993) , which are required for regulated cell proliferation. If expression of MDP is reduced or lost, this might have profound eects on regulated cell growth.
